Teleflex Incorporated (NYSE:TFX – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $277.20.
TFX has been the subject of several recent research reports. Truist Financial reduced their price objective on Teleflex from $264.00 to $255.00 and set a “hold” rating for the company in a research note on Monday, August 7th. Stephens reiterated an “overweight” rating and set a $315.00 price target on shares of Teleflex in a report on Wednesday, October 11th. Morgan Stanley reiterated an “equal weight” rating and set a $261.00 price target on shares of Teleflex in a report on Wednesday, July 19th. JMP Securities reduced their price target on Teleflex from $330.00 to $315.00 and set an “outperform” rating on the stock in a report on Friday, August 4th. Finally, StockNews.com started coverage on Teleflex in a report on Thursday, October 5th. They set a “hold” rating on the stock.
Hedge Funds Weigh In On Teleflex
Teleflex Trading Down 2.4 %
Shares of NYSE:TFX opened at $180.95 on Friday. Teleflex has a 1 year low of $180.84 and a 1 year high of $276.43. The firm has a market capitalization of $8.50 billion, a price-to-earnings ratio of 23.23, a price-to-earnings-growth ratio of 2.02 and a beta of 1.04. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.60 and a quick ratio of 1.47. The business’s 50 day moving average price is $203.14 and its 200-day moving average price is $231.65.
Teleflex (NYSE:TFX – Get Free Report) last announced its earnings results on Thursday, August 3rd. The medical technology company reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.21 by $0.20. Teleflex had a return on equity of 15.48% and a net margin of 12.71%. The firm had revenue of $743.30 million for the quarter, compared to analyst estimates of $729.87 million. During the same quarter last year, the firm posted $3.39 EPS. The business’s revenue was up 5.5% on a year-over-year basis. On average, equities research analysts forecast that Teleflex will post 13.27 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 15th. Stockholders of record on Friday, September 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date was Thursday, September 14th. Teleflex’s dividend payout ratio is presently 17.46%.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
- Five stocks we like better than Teleflex
- What is the NASDAQ Stock Exchange?
- Watch for bears as S&P 500 slices 200-day line
- Insider Trading – What You Need to Know
- Reasons UPS is a strong sell: Reasons to buy it when it bottoms
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 hot mid-caps set to report Q3 earnings
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.